A research team based out of Japan has developed a device for quick identification of a mutation with a strong association to gliomas. This device can be used in real time during surgery and takes less than 15 minutes to determine if a sample tests positive for this mutation. The benefits of this would mean that surgeons can better identify the specific type of tumor and delineate its margins, which can lead to full tumor removal and spare normal brain tissue.
This device works by binding with the sample. If the mutation is present there will be fluorescence, but if the chip in this device comes in contact with normal tissue without the mutation, or with tumor tissue other than glioma, no fluorescence will occur. This technology has the potential to detect cancerous cells in low numbers and eventually make procedures less invasive.
To read this full article, please click here.